ArticleCNS neuroscience & therapeutics2026
EEG Functional Connectivity Associated With Antidepressant Response to Transcutaneous Electrical Cranial-Auricular Acupoint Stimulation.
Article in CNS neuroscience & therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
aimsTranscutaneous electrical cranial-auricular acupoint stimulation (TECAS) is an emerging neuromodulation therapy that integrates principles of acupuncture with noninvasive electrical stimulation. While TECAS has demonstrated efficacy in treating major depressive disorder (MDD), patient responses vary considerably, and the neurophysiological mechanisms remain poorly understood. This clinical study aimed to investigate electroencephalography (EEG)-based functional connectivity (FC) as a potential predictor of clinical response to TECAS in patients with MDD.
methodsResting-state EEG was recorded from 50 MDD patients before and after 8 weeks of TECAS treatment, and from 37 healthy controls (HCs). We compared baseline FC between MDD patients and HCs, pre-to-posttreatment changes in patients, and baseline features between treatment responders and nonresponders. Correlations between FC features and clinical symptom improvements were also assessed.
resultsAfter treatment, frontoparietal θ-band connectivity strength was significantly reduced in MDD. Crucially, pretreatment frontoparietal δ-band connectivity was negatively correlated with posttreatment reductions in depression and anxiety scores. Furthermore, responders demonstrated significantly higher pretreatment β-band FC than nonresponders.
conclusionOur findings indicate that TECAS modulates frontoparietal θ connectivity in MDD. More importantly, pretreatment δ- and β-band FC patterns are associated with therapeutic outcome. These features may serve as potential biomarkers for predicting response to TECAS, facilitating the development of personalized therapeutic strategies for MDD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.